Cable Viewer

Currently released so far... 12613 / 251,287

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/10 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04 2011/05/05 2011/05/06 2011/05/07 2011/05/08 2011/05/09 2011/05/10 2011/05/11 2011/05/12 2011/05/13 2011/05/14 2011/05/15 2011/05/16 2011/05/17

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 94 96 97 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/08
1973/04
1975/03
1979/08
1985/03 1985/05 1985/06
1986/05
1987/06
1988/01 1988/03 1988/07
1989/12
1990/01 1990/07 1990/08 1990/10
1991/05
1992/01 1992/03 1992/06 1992/09 1992/12
1993/01 1993/10
1994/12
1996/11
1997/06 1997/12
2000/05 2000/06 2000/09 2000/11
2001/02 2001/03 2001/06 2001/07 2001/09 2001/10 2001/11
2002/01 2002/02 2002/03 2002/04 2002/07 2002/08 2002/09 2002/11
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Adana American Institute Taiwan, Taipei
Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Barcelona
Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chennai Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar Consulate Dubai
Embassy Freetown Consulate Fukuoka
Embassy Guatemala Embassy Gaborone Consulate Guayaquil Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Istanbul
Embassy Jakarta Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Kolkata
Embassy Luxembourg Embassy Luanda Embassy London Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy La Paz Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Melbourne
Embassy Nicosia Embassy Niamey Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Naples Consulate Naha
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Prague Embassy Port Of Spain Embassy Port Louis Embassy Port Au Prince Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sapporo Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana
USUN New York USEU Brussels US Office Almaty US Mission Geneva US Interests Section Havana US Delegation, Secretary UNVIE Embassy Ulaanbaatar
Embassy Vilnius Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
AS AM AR AMGT ASEC AFIN AL AORC AU AG AF APER ABLD ADCO ABUD AID AMED AJ AEMR AE ASUP AN AY AIT ADPM APEC ACOA ANET APECO ASIG AA ASEAN AGAO AADP AMCHAMS ARF AGR ATRN ALOW ACS APCS AFFAIRS ADANA AECL ACAO AORG AROC AO AODE ACABQ AGMT AX AMEX AFGHANISTAN AZ AND ARM AQ ATFN AMBASSADOR ACBAQ AFSI AFSN AC AUC ASEX AINF AER AVERY AGRICULTURE ASCH AFU AMG ATPDEA ASECKFRDCVISKIRFPHUMSMIGEG AORL ADM
BA BM BR BL BH BO BK BD BEXP BU BILAT BTIO BF BT BX BG BY BE BP BC BBSR BB BRUSSELS BIDEN BMGT BWC BN BTIU
CO CS CA CD CR CPAS CH CDG CI CU CE CBW CVIS CASC CDC CONS CMGT CV CY CIA CW CIDA CWC CG CJAN CODEL CT CM CAPC CTR CACS CLINTON CBSA CEUDA COM CF CARSON CN CIC COPUOS CONDOLEEZZA CICTE COUNTER COUNTRY CBE CFED CL CKGR CHR CVR COUNTERTERRORISM CITEL CLEARANCE COE CARICOM CB CSW CITT CACM CDB CJUS CTM CAN CLMT CBC CAC CNARC CROS CIS
DEAX DA DHS DAO DCM DJ DR DOD DOMESTIC DO DK DPRK DEPT DEA DISENGAGEMENT DE DOE DTRA DS DEFENSE
ETTC EN ENRG EAGR EAID ECIN EFIN EINT EINV ETRD EUN ECON EAIR EWWT EG EPET EMIN EU EFIS ELTN ELAB EC EIND ECPS ENVR EZ ET ENERG EI ETRN EUREM EINVECONSENVCSJA ER EEPET EUNCH EFTA EXIM EK ES ETRDEINVECINPGOVCS ESENV ENNP ENVI ESA ELN ETRDECONWTOCS EFINECONCS EUMEM ENGR ERNG ELECTIONS ECA EPA ETRC EXTERNAL EINVEFIN EUR ETC EAP ENIV ECONOMY EINN ECONOMIC EXBS ECUN ENGY ECONOMICS EIAR EINDETRD ECONEFIN EURN EDU ETRDEINVTINTCS ECIP EFIM EAIDS EREL EINVETC ECONCS ETRA ECINECONCS EAIG ETRO EUC ERD
FR FI FTAA FJ FBI FO FM FDA FAO FAS FREEDOM FTA FISO FOR FARC FAC FINR FINANCE FOI FOREIGN FMLN
GG GV GM GH GT GR GA GE GY GANGS GTIP GAERC GOI GOV GTMO GL GF GCC GZ GAZA GLOBAL GERARD
HR HEBRON HSTC HA HUMOR HU HO HK HILLARY HI HURI HUMAN HYMPSK
IR IS IC IZ IAEA IN ICRC IT ID IDA IWC IO ICJ ICAO IV IAHRC IBRD IMF IQ INRA INRO ILC IGAD IMO ITRA ICTY ITU ILO ISLAMISTS ICTR IBET IRC IRAQI ITALY IPR ISRAELI IIP INMARSAT ITPGOV ITALIAN INTERNAL IRS IA INTERPOL IEA INRB IL INR IZPREL IRAJ ITF IF ITPHUM ISRAEL IACI IEFIN INTELSAT INDO IDP
JA JO JM JP JUS JAMES JOHNNIE JOSEPH JOHN
KSCA KSUM KIPR KTEX KJUS KIDE KDEM KIRF KV KNNP KTIA KN KGHG KG KISL KTFN KUNR KCRM KPWR KPAL KTIP KFRD KWMN KOLY KPAO KMDR KCOR KPRP KU KZ KPKO KO KOMS KAWC KMCA KMPI KFLU KGIC KOMC KRVC KVRP KS KSEP KIRC KSPR KVPR KWBG KACT KFLO KFSC KHIV KHSA KMFO KCIP KENV KHLS KDRG KSAF KRAD KNSD KBCT KBTR KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KCFE KE KSTC KCGC KR KPOA KPLS KICC KRIM KAWK KWMM KPRV KVIR KTDB KX KCRS KMOC KCRCM KBTS KSEO KHDP KFIN KSTH KOCI KGIT KNUP KTBT KPAONZ KNUC KNNPMNUC KWAC KERG KSCI KBIO KTLA KCSY KTRD KNAR KMRS KNPP KJUST KCMR KTER KRCM KNEI KCFC KSAC KCHG KGCC KREL KFTFN KCOM KLIG KDEMAF KAID KPAI KICA KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KHUM KREC KSEC KPIN KESS KDEV KWWMN KOM KWNM KRFD KMIG KDDG KRGY KIFR KID KWMNCS KPAK
LE LY LH LU LI LG LO LA LTTE LAB LOG LT LABOR
MTCRE MNUC MARR MOPS MASS MX MK MO MCAP MIL MAS ML MR MEDIA MAR MC MD MG MI MY MU MTRE MA MQADHAFI MASC MW MARAD MPOS MRCRE MTCR MAPP MZ MP MOPPS MTS MLS MILI MEPN MEPI MEETINGS MERCOSUR MT MCC MIK MAPS MV MILITARY MDC MEPP MASSMNUC MUCN
NL NZ NI NPT NATO NO NK NS NU NP NG NA NSG NT NW NE NSF NR NPA NAFTA NASA NSFO NDP NGO NORAD NSSP NATIONAL NIPP NZUS NH NC NEW NRR NAR NV NATOPREL NPG NSC
OREP OSCE OSCI OTRA OVIP OPDC OAS OIIP OPRC OPAD OBSP OEXC OECD OFDP OFFICIALS ODIP OPIC OHUM OES OPCW OVP OCS OIE OTR OMIG OSAC OFDA OIC ON OCII
PARM PGOV PREL PTER PE PHUM PINR PINS PREF PM PK POL PBTS PNAT PHSA PAS PA PO PDOV PL PHUMPGOV PAK PGIV PAO PHUMPREL PCI PROP PP PTBS PINL POV PEL PG PREO PAHO PREFA PSI POLITICAL POLITICS PAIGH POSTS PMIL PRAM PALESTINIAN PARMS PROG PBIO PTERE PRGOV PORG PS PGOF PKFK PSOE PEPR PPA PINT PMAR PRELP PINF PNG PFOR PUNE PGOVLO PHUMBA PSEPC POGOV POLICY PNR POLINT PGOVE PHALANAGE PARTY PDEM PECON PROV PBT PGOC PY PLN PHUH PF PRL PHUS PU PARTIES PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA
QA
RS RU REGION REACTION REPORT RO RW RP RFE RM RCMP RSO ROBERT RICE RSP RF ROOD RIGHTS RIGHTSPOLMIL RUPREL RELATIONS
SNAR SENV SY SP SU SOCI SMIG SR SCUL SF SO SA SI SARS SZ SW SG SIPRS SEVN SNARCS SYR SN STEINBERG SH SAARC SC SCRS SYRIA SL SENVKGHG SAN ST SIPDIS SNARIZ SNARN SSA SK SPCVIS SOFA SANC SWE SHI SEN SHUM SPCE
TSPA TU TBIO TD TT TS TRGY TINT TF TPHY TN TH TSPL TW TC TX TZ THPY TL TV TNGD TI TP TBID TK TERRORISM TIP TO TRSY TURKEY TFIN TAGS TR
UNESCO UK UNGA UN UNMIK UNHRC UP UNSC USTR US UNDC UY UNICEF UV UNDP UNAUS UNCSD USUN USOAS USNC UNEP UNHCR UNCND UNFCYP UNIDROIT UG UZ UNCHC UNCHR USEU USPS USAID UE UNVIE UAE UNO UNODC UNCHS UNFICYP UNDESCO UNC UNPUOS
VZ VT VE VI VM VTPREL VN VTIZ VTEG VAT VC
WHTI WTRO WTRQ WBG WHO WFP WI WS WMD WIPO WTO WHA WZ WB WWARD WITH WEU WMO WA
XR XS XA XV XH XF XL XG XM XT XK XD XI XE XW XB XQ XX XTAG XY XZ XU XC
YI YM YE YMCS
ZI ZP ZR ZK ZO ZU ZL ZOELLICK ZF ZB ZJ ZEALAND ZN ZA ZANU

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 08HELSINKI311, FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #08HELSINKI311.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
08HELSINKI311 | 2008-07-09 09:35 | 2011-04-24 00:00 | UNCLASSIFIED | Embassy Helsinki

`

    VZCZCXYZ0002
    RR RUEHWEB

    DE RUEHHE #0311/01 1910935
    ZNR UUUUU ZZH
    R 090935Z JUL 08
    FM AMEMBASSY HELSINKI
    TO RUEHC/SECSTATE WASHDC 4415
    RUCPDOC/DEPT OF COMMERCE WASHDC
    INFO RUCNMEU/EU INTEREST COLLECTIVE
    RUEHNY/AMEMBASSY OSLO 4744

` `

    UNCLAS HELSINKI 000311

    SIPDIS

    E.O. 12958: N/A
    TAGS: ETRD FI PREL
    SUBJECT: FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

    REFERENCE PRICING SYSTEM

    ¶1. Summary:  In a disappointing move and despite Embassy and
    industry efforts, the Finnish cabinet voted unanimously June
    25 to approve a reference pricing scheme for pharmaceuticals,
    a provision of which undermines the value of patent
    protection for medicines created and manufactured by U.S. and
    other pharmaceutical companies. Parliament is expected to
    approve the proposal at the end of the summer.  Despite the
    fact that the Ministry of Economy and Employment, the
    Ministry of Foreign Affairs and the Chancellor of Justice
    initially opposed the proposal and Prime Minister Vanhanen
    was equivocal, in the end all acquiesced and supported the
    Minister of Social Affairs and Health and the short-term
    attraction of an estimated 50 million euros annually in
    savings.  Embassy will engage key parliamentary figures in
    the next month to urge that the government develop a revised
    proposal that achieves their stated objective of containing
    health care costs but that will maintain the level of
    intellectual property protection that pharmaceutical
    companies have previously enjoyed in Finland and continue to
    enjoy elsewhere in the European Union.  If the proposal
    passes as written, post will consult with local U.S. industry
    and Washington to determine if a Special 301 listing is
    appropriate in the 2009 cycle.  End Summary.

    ----------
    Background
    ----------

    ¶2.  Product patents have been granted in Finland only since
    ¶1995.  As such, nearly all products on the Finnish market are
    still protected only by analoguous process patents.  Prior to
    2006, when Finland enacted the fix it is now proposing to
    withdraw, the level of protection for innovative medicines in
    Finland was among the lowest in the EU.  At that time,
    industry faced three major hurdles that taken together formed
    a perfect storm:  weak patent protection, liberal market
    authorization and mandatory generic substitution.

    --------------------------------------------- -------
    Finland Does the Right Thing But Then Changes Course
    --------------------------------------------- -------

    ¶3.  After much Industry and Embassy lobbying, in 2006, the
    Finnish government established criteria in Section 57(c) of
    its Medicines Act that excluded pharmaceutical products from
    generic reimbursement if they were protected by an analogus
    process patent in Finland and enjoyed valid patent protection
    in at least five other countries in the European Union.
    57(c) was the result of long negotiations and was seen by
    industry as a fair and equitable solution.  Indeed, it was
    used as an example for other countries, notably Norway, of
    the ideal legislative remedy.  Trouble started in the summer
    of 2007 when the Finnish Pharmaceutical Pricing Board (PPB)
    began cancelling the reimbursement status of some innovative
    drugs, claiming the PPB was bound only by the Health
    Insurance Act, not the the Medicines Act that contained the
    exclusion criteria. At first, Industry and Econoff believed
    this was an isolated action by an overzealous PPB chief,
    especially because when we raised it with the newly-installed
    Health Minister, she freely admitted she did not know what we
    were talking about.  Clearly she eventually got up to speed,
    because before long her ministry was overtly supporting the
    complete withdrawal of the 57(c) arrangement instead of
    supporting similar exclusion criteria for the Health
    Insurance Act as industry was proposing.

    ------------------------
    USG and Industry Efforts
    ------------------------

    ¶4. Beginning late last year, Econoff and Commercial Officer
    began working closely with the U.S. pharmaceutical company
    representatives here in Finland as well as with the local
    trade association Pharma Industry Finland (PIF) and its
    director, former Finance Minister Suvi-Anne Siimes to devise
    a strategy to head off the cancellation of 57(c).  Since
    January 2008 the Embassy has raised this at the highest level
    of Finnish government, including with the Prime Minister but
    also with virtually every other minister in the entire
    government.  Our strategy, carefully coordinated with
    industry and Washington, has focused on underscoring that
    Finland's knowledge-based economy has attracted much r&d
    investment, including health-related project funds from the
    USG.  A small IPR deficiency would undermine Finland's
    deserved reputation for innovation, a blow that was surely
    not worth the short-term gains from savings.  Industry
    reinforced this message during the visit of Alex Azar, Eli
    Lilly's Senior VP for Corporate Affairs (and a former Deputy
    Secretary of HHS) and through intensive lobbying by PIF and
    Siimes.  Siimes has also reached out to the German, French

    and Swiss Embassies whose companies also stand to suffer
    under the new arrangement.  USTR Ambassador Schwab and
    Secretary Gutierrez have written their Finnish counterparts
    on this issue and it has been raised with the Finnish Embassy
    in Washington and during the visits of high-level Finnish
    government officials.

    ----------
    Next Steps
    ----------

    ¶5.  With the cabinet's approval of the reference pricing
    scheme and the subsequent removal of the protection
    innovative products enjoyed under Section 57(c), there are
    few steps left.  Nonetheless, Embassy has a small window
    until the end of the summer when parliament will reconvene
    and consider the proposal.  Given that the MPs' party
    representatives in the cabinet have already approved the
    proposal, however, chances for success are slim.  However, we
    remain committed to raising this with parliamentary leaders
    in an attempt to encourage the development of a revised
    proposal.  If that fails, we will examine whether this
    unfortunate set of events merits Finland's inclusion on the
    Special 301 list.

    BUTLER

`